Articles from: American Society of Hematology
Recent advances in the knowledge of the pathophysiology and molecular basis of iron metabolism highlight that hemochromatosis is caused by mutations in at...
-
RT @drkpavithran: Hemochromatosis classification-BIOIRON Society recommendations https://t.co/ICshgG1aUs https://t.co/ICshgG1aUs - view on twitter
-
RT @drkpavithran: Hemochromatosis classification-BIOIRON Society recommendations https://t.co/ICshgG1aUs https://t.co/ICshgG1aUs - view on twitter
Mashup Score:1
American Society of HematologyHemochromatosis classification: update and recommendations by the BIOIRON Society - 12 hours
Mashup Score:1
Recent advances in the knowledge of the pathophysiology and molecular basis of iron metabolism highlight that hemochromatosis is caused by mutations in at...
-
Hemochromatosis classification-BIOIRON Society recommendations https://t.co/ICshgG1aUs https://t.co/ICshgG1aUs - view on twitter
Mashup Score:3
American Society of HematologyKey Points. Weight and height Z-scores decreased during therapy; after therapy, weight and BMI Z-scores increased but height Z-scores remained low.The...
-
Weight and height Z-scores decreased during therapy; after therapy, weight and BMI Z-scores increased but height Z-scores remained low. https://t.co/qywTxuRdsu #myeloidneoplasia #clinicaltrialsandobservations https://t.co/qywTxuRdsu - view on twitter
Mashup Score:1
American Society of HematologyHLA-DQ + CD4 help = graft-versus-tumor effect - 23 hours
Mashup Score:1
In this issue of Blood, Petersdorf et al demonstrate a new paradigm for hematopoietic cell transplantation (HCT) donor selection that has an impact on the...
-
HLA-DQ + CD4 help = graft-versus-tumor effect https://t.co/a6zzNkl385 - view on twitter
Mashup Score:13
American Society of HematologyHLA-DQ + CD4 help = graft-versus-tumor effect - 1 day
Mashup Score:13
In this issue of Blood, Petersdorf et al demonstrate a new paradigm for hematopoietic cell transplantation (HCT) donor selection that has an impact on the...
-
RT @BloodJournal: HLA-DQ + CD4 help = graft-versus-tumor effect https://t.co/X2hwp2lJv7 - view on twitter
Zhao Yan, Han Xiaoxu; Paranuclear blue inclusions in metastatic rhabdomyosarcoma of the bone marrow, Blood, Volume 139, Issue 20, 19 May 2022, Pages 3099,...
-
RT @BloodJournal: Blood Work: Paranuclear blue inclusions in metastatic rhabdomyosarcoma of the bone marrow https://t.co/J1pFulDX0a https:/… - view on twitter
Zhao Yan, Han Xiaoxu; Paranuclear blue inclusions in metastatic rhabdomyosarcoma of the bone marrow, Blood, Volume 139, Issue 20, 19 May 2022, Pages 3099,...
-
RT @BloodJournal: Blood Work: Paranuclear blue inclusions in metastatic rhabdomyosarcoma of the bone marrow https://t.co/J1pFulDX0a https:/… - view on twitter
Mashup Score:18
American Society of HematologyImpact of Etoposide and ASCT on Survival Among Patients - 2 days
Mashup Score:18
Key Points. In advanced stage T-cell lymphoma, the addition of etoposide to CHOP improved OS for ALK+ ALCL, but not for ALK- ALCL, AITL...
-
🗝️KEY POINTS ▪️Addition of etoposide to CHOP improved OS for ALK+ ALCL, but not for ALK- ALCL, AITL and PTCL NOS. ▪️Consolidation with ASCT in first-line significantly increased OS for ALK- ALCL, AITL and PTCL NOS 👉 https://t.co/nBnjqSEUiU 👈 #lymsm #lymphoma - view on twitter
Mashup Score:2
American Society of HematologyReal-World Use of Tisagenlecleucel in Infant Acute Lymphoblastic Leukemia - 3 days
Mashup Score:2
Key Points. Real world use of tisagenlecleucel in infant B-ALL shows that this novel therapy can be effective and safe in a highly aggressive...
-
Real-World Use of Tisagenlecleucel in Infant Acute Lymphoblastic Leukemia https://t.co/IkWybGYTOT #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy #Gene #Genetherapy @ASTCT @BloodAdvances @ASH_hematology - view on twitter
Key Points. MH fusion impairs B-cell development and cooperates with NRASG12D mutation to trigger B-cell precursor acute lymphoblastic leukemia.MEF2D-DNA...
MEF2D-HNRNPUL1 fusions (poor progn in pts w B-ALL) impair B cell devel & cooperate w NRASG12D mut to trigger B-ALL; targeting fusion-driven transact of HDAC family w panobinostat + chemo had antitumour activity in mouse models of B-ALL harbouring NRASG12D: https://t.co/5M57S5UYBe - view on twitter